Development of generic calcium imaging assay for monitoring gi-coupled receptors and g-protein interaction

Journal of Biomolecular Screening

Volumn 14, Issue 7, 2009, Pages 781-788

  Ueda, Takashi ^a   Ugawa, Shinya ^a   Ishida, Yusuke ^a   Hondoh, Aki ^a   Shimada, Shoichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

5 HT1A serotonin receptor; Chimeric G proteins; D2L dopamine receptor; G 16; Gi coupled receptors

Indexed keywords

CALCIUM; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PHOSPHOROTHIOIC ACID S 3 (3 METHYLAMINOPROPYLAMINO)PROPYL ESTER; QUINPIROLE; SEROTONIN 1A RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELL ASSAY; CHIMERA; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SCREENING;

ANIMALS; BIOLOGICAL ASSAY; CALCIUM; CALCIUM SIGNALING; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HL-60 CELLS; HUMANS; INTRACELLULAR SPACE; LIGANDS; MICE; MOLECULAR IMAGING; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; SEROTONIN;

EID: 69549107440     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057109335258     Document Type: Article

References (28)

1. Offermanns S., Simon MI: G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995 ; 270: 15175-15180.
2. Mody SM, Ho MK, Joshi SA, Wong YH: Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors. Mol Pharmacol 2000 ; 57: 13-23.
3. Wong CS, Ho MK, Wong YH: The beta6/alpha5 regions of Galphai2 and GalphaoA increase the promiscuity of Galpha16 but are insufficient for pertussis toxin-catalyzed ADP-ribosylation. Eur J Pharmacol 2003 ; 473: 105-115.
4. Ueda T., Ugawa S., Yamamura H., Imaizumi Y., Shimada S.: Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells. J Neurosci 2003 ; 23: 7376-7380.
5. Cordeaux Y., Nickolls SA, Flood LA, Graber SG, Strange PG: Agonist regulation of D(2) dopamine receptor/G protein interaction: evidence for agonist selection of G protein subtype. J Biol Chem 2001 ; 276: 28667-28675.
6. Liu YF, Jakobs KH, Rasenick MM, Albert PR: G protein specificity in receptor-effector coupling: analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. J Biol Chem 1994 ; 269: 13880-13886.
7. Gettys TW, Fields TA, Raymond JR: Selective activation of inhibitory G-protein alpha-subunits by partial agonists of the human 5-HT1A receptor. Biochemistry 1994 ; 33: 4283-4290.
8. Gazi L., Nickolls SA, Strange PG: Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Br J Pharmacol 2003 ; 138: 775-786.
9. Lane JR, Powney B., Wise A., Rees S., Milligan G.: Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)- N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1, Gi2, and Gi3. Mol Pharmacol 2007 ; 71: 1349-1359.
10. Conklin BR, Farfel Z., Lustig KD, Julius D., Bourne HR: Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature 1993 ; 363: 274-276.
11. Noel JP, Hamm HE, Sigler PB: The 2.2 A crystal structure of transducinalpha complexed with GTP gamma S. Nature 1993 ; 366: 654-663.
12. Gilchrist A., Li A., Hamm HE: G alpha COOH-terminal minigene vectors dissect heterotrimeric G protein signaling. Sci STKE 2002 ; 2002: PL1.
13. Kushwaha N., Albert PR: Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling. Eur J Neurosci 2005 ; 21: 721-732.
14. Raymond JR, Mukhin YV, Gettys TW, Garnovskaya MN: The recombinant 5-HT1A receptor: G protein coupling and signalling pathways [review]. Br J Pharmacol 1999 ; 127: 1751-1764.
15. Siehler S.: Cell-based assays in GPCR drug discovery [review]. Biotechnol J 2008 ; 3: 471-483.
16. Eglen RM, Bosse R., Reisine T.: Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening [review]. Assay Drug Dev Technol 2007 ; 5: 425-451.
17. Burris KD, Molski TF, Xu C., Ryan E., Tottori K., Kikuchi T., et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002 ; 302: 381-389. (Pubitemid 34680462)
18. Urban JD, Vargas GA, von Zastrow M., Mailman RB: Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 2007 ; 32: 67-77.
19. Oz M., Zhang L., Rotondo A., Sun H., Morales M.: Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors. Synapse 2003 ; 50: 303-313.
20. Garnovskaya MN, Gettys TW, van Biesen T., Prpic V., Chuprun JK, Raymond JR: 5-HT1A receptor activates Na+/H+ exchange in CHO-K1 cells through Gialpha2 and Gialpha3. J Biol Chem 1997 ; 272: 7770-7776.
21. Raymond JR, Olsen CL, Gettys TW: Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry 1993 ; 32: 11064-11073.
22. Mannoury la Cour C., El Mestikawy S., Hanoun N., Hamon M., Lanfumey L.: Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 2006 ; 70: 1013-1021.
23. Kostenis E.: Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors [review]? Trends Pharmacol Sci 2001 ; 22: 560-564.
24. Ho MK, Chan JH, Wong CS, Wong YH: Identification of a stretch of six divergent amino acids on the alpha5 helix of Galpha16 as a major determinant of the promiscuity and efficiency of receptor coupling. Biochem J 2004 ; 380 (pt 2). 361-369.
25. Tadori Y., Miwa T., Tottori K., Burris KD, Stark A., Mori T., et al. Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. Eur J Pharmacol 2005 ; 515 (1-3). 10-19.
26. Raymond JR, Albers FJ, Middleton JP: Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 1992 ; 346: 127-137.
27. McLoughlin DJ, Strange PG: Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors. J Neurochem 2000 ; 74: 347-357.
28. Jordan S., Koprivica V., Chen R., Tottori K., Kikuchi T., Altar CA: The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002 ; 441: 137-140. (Pubitemid 34626163)